Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0UOMXH
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Ab2-AM2 (D265C LALA H435A)
|
|||||
| Synonyms |
Ab2-AM2 (D265C LALA H435A)
Click to Show/Hide
|
|||||
| Organization |
Vor Biopharma Inec.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1.8
|
|||||
| Antibody Name |
undisclosed
|
|||||
| Antigen Name |
Receptor-type tyrosine-protein phosphatase C (PTPRC)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
General Information of The Activity Data Related to This ADC
Revealed Based on the Cell Line Data
Full List of Activity Data of This Antibody-drug Conjugate
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (IC50) | 0.0055 nM | Positive CD45,Ab2 expression (CD45,Ab2 +++/++) | ||
| Method Description |
In vitro cell line killing assay - IC50 values
|
||||
| In Vitro Model | Normal | PBMC cells | CVCL_0140 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (IC50) | 0.0126 nM | Positive CD45,Ab2 expression (CD45,Ab2 +++/++) | ||
| Method Description |
in vitro HSC PBMC killing assay (stimulated vs non-stimulated) IC50 values
|
||||
| In Vitro Model | Normal | PBMC cells | CVCL_0140 | ||
| Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (IC50) | 0.266 nM | Positive CD45,Ab2 expression (CD45,Ab2 +++/++) | ||
| Method Description |
in vitro HSC PBMC killing assay (stimulated vs non-stimulated) IC50 values
|
||||
| In Vitro Model | Normal | PBMC cells | CVCL_0140 | ||